Aberrant immunohistochemical expression of CD4 as a rare finding in metastatic melanoma

J Cutan Pathol. 2020 Dec;47(12):1223-1226. doi: 10.1111/cup.13792. Epub 2020 Oct 3.

Authors

Kyriakos Chatzopoulos¹, Daniel R O'Brien², Sotiris Sotiriou¹, Khashayarsha Khazaie³, Jin Jen^{1

4}, Jean-Pierre A Kocher², Svetomir N Markovic⁵, Thomas J Flotte¹

Affiliations

¹ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
² Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
³ Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.
⁴ Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.
⁵ Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.

PMID: 32594533
DOI: 10.1111/cup.13792

No abstract available

Publication types

Case Reports

MeSH terms

Adult
CD4 Antigens / biosynthesis*
Female
Humans
Immunohistochemistry
Male
Melanoma* / immunology
Melanoma* / metabolism
Melanoma* / pathology
Melanoma, Cutaneous Malignant
Middle Aged
Skin Neoplasms* / immunology
Skin Neoplasms* / metabolism
Skin Neoplasms* / pathology

Substances

CD4 Antigens

Grants and funding

Mayo Clinic Institutional Research Funds